Search Within

David Hyman

  1. "Oxford University Press"
Formats
  1. Meeting Abstract (16)
  2. Journal Article (9)
  3. Editorial (1)
Groups
  1. Department of Medicine (26)
  2. Early Drug Development Service (26)
  3. Solid Tumor Oncology Division (26)
  4. Thoracic Oncology (12)
  5. GSK Faculty (10)
  6. Human Oncology and Pathogenesis Program (8)

More Groups

People
  1. Alexander Drilon (12)
  2. Alison Schram (5)
  3. David Solit (4)
  4. Marc Ladanyi (4)
  5. Michael Berger (4)
  6. Nikolaus Schultz (4)

More People

Years
  1. 2020 (3)
  2. 2019 (14)
  3. 2018 (1)
  4. 2017 (3)
  5. 2016 (4)
  6. 2014 (1)
Publications
  1. Annals of Oncology (22)
  2. Neuro-Oncology (3)
  3. Journal of the American Medical Informatics Association (1)
Publishers
  1. Oxford University Press (26)

Results (26)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Oncologist use and perception of large panel next-generation tumor sequencing
    Journal Article

    Schram, A. M.; Reales, D.; Galle, J.; Cambria, R.; Durany, R.; Feldman, D.; Sherman, E.; Rosenberg, J.; D'Andrea, G.; Baxi, S.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • A phase II basket study of the oral TRK inhibitor LOXO-101 in adult subjects with NTRK fusion-positive tumors
    Meeting Abstract

    Drilon, A.; Hong, D.; Deeken, J.; Smith, S.; Reynolds, M.; Cruickshank, S.; Deegan, M.; Ku, N.; Hyman, D.
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Lurbinectedin (PM01183) plus paclitaxel (P), recommended dose (RD) expansion results with or without the addition of bevacizumab (Bev) in patients (pts) with selected solid tumors
    Meeting Abstract

    Drilon, A.; Garralda, E.; Stathis, A.; Szyldergemajn, S.; Hyman, D.; Boni, V.; Griguolo, G.; Martinez, E. J.; Makker, V.; Canziani, L.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Automated eligibility screening and monitoring for genotype-driven precision oncology trials
    Journal Article

    Eubank, M. H.; Hyman, D. M.; Kanakamedala, A. D.; Gardos, S. M.; Wills, J. M.; Stetson, P. D.
    Journal of the American Medical Informatics Association (2016)

    Fulltext@MSK | Save
  • What hides behind the MASC: Clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC)
    Journal Article

    Drilon, A.; Li, G.; Dogan, S.; Gounder, M.; Shen, R.; Arcila, M.; Wang, L.; Hyman, D. M.; Hechtman, J.; Wei, G.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • The performance of BRCA1 immunohistochemistry for detecting germline, somatic, and epigenetic BRCA1 loss in high-grade serous ovarian cancer
    Journal Article

    Meisel, J. L.; Hyman, D. M.; Garg, K.; Zhou, Q.; Dao, F.; Bisogna, M.; Gao, J.; Schultz, N. D.; Grisham, R. N.; Phillips, M.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save